Sebia’s gel technology is based on the principle of separating of molecules in an agarose medium.
Three types of separation occur according to:
With more than 50 years of experience in Gel Electrophoresis and more than 60 references, Sebia continues to develop and design the largest range of assays with the highest quality of standards.
The gel menu covers multiple pathologies including oncology (Multiple Myeloma), metabolic disorders such Hemoglobinopathies and rare pathologies in order to screen and monitor patients.
The multifunctional HYDRASYS 2 SCAN FOCUSING analyzer allows simultaneous sample analyses on one gel. Coupled with the ASSIST sample application, migration, washing, staining and scanning are performed on-board automatically in order to quantify the protein fractions.
Sebia’s gel solutions gives you confidence when reporting your patients’ results with best-in-class gel electrophoresis assays.
The HYDRASHIFT portfolio include IVD test to mitigate interferences seen in immunofixation result for patient treated with daratumumab.
Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians.
2005 Multiple sclerosis consensus criteria includes CSF IgG oligoclonal bands.
2017 Mc Donald Criteria for multiple sclerosis diagnosis includes CSF IgG oligoclonal bands.
Evaluation of Sebia’s isoelectrofocusing kit for A1AT with HYDRASYS.
Immunotherapies for Multiple Myeloma, like the monoclonal antibody daratumumab, can create false positive IgG Kappa bands on Immunofixation gels. This paper describes best practice guidelines for using the Hydrashift assay to remove daratumumab interference from Immunofixation gels.
Educational Webinar with Prof. Alessandro Gozzetti, MD, PhD
Educational Webinar with Katie Thoren, PhD, Memorial Sloan Kettering Cancer Center
Learn how a Sebia customer utilized our Workflow Service offering and CAPILLARYS 3 instruments to achieved higher throughput and improved workflow.
Educational Webinar with Dr. Julien GUILLEMAUD
Learn how a Sebia customer gained both clinically and operationally with a simplified IT workflow.
The gold standard assay to objectively detect CNS local IgG synthesis in multiple sclerosis.
The gold standard assay for the alpha 1-antitrypsin (A1AT) phenotype testing.
Proteinuria screening for renal disease.
Identification of monoclonal proteins by agarose gel electrophoresis.
The high-resolution method for hemoglobin disorders screening.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.